In chapter 1, we describe development of a mild and efficient method for SNAr iodination of 6-chloropurine 2'-deoxynucleosides and nucleosides. Our studies demonstrate that 6-iodopurine nucleosides are excellent substrates for certain transition metal-catalyzed cross-coupling reactions. In chapter 2, we describe synthesis of protected 6-fluoro, 6-chloro, 6-bromo and 6-sulfonylpurine nucleosides. Comparisons among 6-fluoro-, 6-chloro-, 6-bromo, 6-iodo and 6-sulfonylpurine nucleosides for SNAr reactions with various N, O and S nucleophiles were investigated. Our results demonstrate that the 6-fluoropurine nucleoside is the best substrate for SNAr reactions among the four 6-halopurine nucleosides with oxygen, sulfur and aliphatic amine nucleophiles, and also with an aromatic amine plus TFA as a catalyst. However, the 6-iodopurine nucleoside is the best substrate for the aromatic amine without acid. With oxygen and sulfur nucleophiles, the 6-sulfonylpurine nucleoside reacted even faster than the 6-fluoropurine nucleoside. In chapters 3 and 4, nickel- and palladium-based systems with imidazolium-carbene ligands can catalyze efficient Suzuki cross-couplings of arylboronic acids and 6-[(imidazol-1-yl)-, (1,2,4-trizaol-4-yl), fluoro, alkylsulfanyl and alkylsulfonyl]purine 2'-deoxynucleosides and nucleosides to give the corresponding 6-arylpurine products.

Loline alkaloids (LA) are secondary metabolites produced by Epichloandamp;euml; (anamorph, Neotyphodium) grass endophytes. They are toxic and deterrent to a broad range of herbivorous insects but not to livestock. This protective bioactivity has spurred considerable research into the LA biosynthetic pathway. LOL, the gene cluster containing nine genes, is required for LA biosynthesis. The regulation of LOL genes during LA production in culture and in symbio is of interest. In this study, coordinate regulation between LOL gene expression and LA production level was investigated in both MM culture and symbiota. Results showed that expression of LOL genes in N. uncinatum MM culture were tightly correlated with each other (p andamp;lt; 0.0005), and all presented a significant temporal quadratic pattern during LA production. Gene expression started before LA were detectable, and increased while LA accumulated. The highest gene expression level was reached before the highest amounts of LA were detected, and gene expression level declined to a very low level after amounts of LA plateaued. Observations suggested that the hierarchical clusters based on the correlation coefficient could help to predict the roles of LOL genes in the LA pathway. In symbiota, coordinate coregulation of LOL gene expression with LA was found in E. festucae-meadow fescue inflorescences and stromata, whereby lower LOL gene expression corresponded with the lower LA level in stromata. In N. uncinatum (or N. siegelii)-meadow fescue vegetative tissues, dramatically higher LA levels were found in younger leaf tissue than in older leaf tissue, yet no evidence was found to relate this difference to LOL gene expression differences. Instead, substrate availability may regulate the LA level. In particular, asparagine was more than 10-fold higher in young leaf tissue than in old tissue, although proline was significantly lower in young tissue. Therefore, different regulatory mechanisms underlie LOL gene expression and LA production in different circumstances. The GUS activity of Pro-lolC2-GUS and Pro-lolA2-GUS in Neotyphodium species was almost undetectable in culture, though the activity could be detected in symbiota. The mRNA of GUS did not exhibit the same pattern as lolC2 or lolA2 in culture during LA production time course. A Pro-lolC2-cre transgene was expressed in complex medium, in which lolC2 mRNA was not detectable. These results suggest that proper regulation of LOL genes in culture or symbiota is dependent on the LOL cluster.

The pentafluorosulfanyl (SF5) group displays remarkable and unique properties, including large dipole moment, high electronegativity, high thermal and chemical stability, as well as high lipophilicity. However, only a few synthetic methods for the preparation of aromatic pentafluorosulfanyl building blocks have been developed to date. This work aims at improving availability and accessibility of aryl sulfurpentafluoride building blocks. In the first part of the work, the synthesis of aryl sulfurpentafluorides by the direct fluorination of diaryl disulfides with elemental fluorine is described. Nowadays, this synthetic strategy is used by industry on a multi-kilogram scale. However, the scope of the reaction is only limited to 3- and 4- nitro-1-(pentafluorosulfanyl)benzenes. In this work, the synthesis of various para-, meta- and ortho-substituted-(pentafluorosulfanyl)benzenes following the same approach was carried out. In the second part, the derivatization of aryl sulfurpentafluoride building blocks was investigated. Direct fluorination of 3-nitro-1-(pentafluorosulfanyl)benzene afforded 3-fluoro-5-nitro-1- (pentafluorosulfanyl)benzene. The titled compound was derivatized by two different processes: nucleophilic aromatic substitution (SNAr) of fluorine and vicarious nucleophilic substitution of...

No description available.

No description available.

No description available.

Orientador: Prof. Dr. Rodrigo Luiz Oliveira Rodrigues Cunha / Dissertação (mestrado) - Universidade Federal do ABC, Programa de Pós-Graduação em Ciência & Tecnologia - Química, 2014. / Errata: Folha 4, linha 20. Onde se lê "Figura 1. Imagem de microscopia evidanciando o anel trofozoíta (no centro em destaque), leia-se Figura 1. Imagem de microscopia evidanciando o anel trofozoíta (no centro, em destaque). Fonte: https://pt.wikipedia.org/wiki/ficheiro:Plasmodium_ovale_01.png / As doenças tropicais negligenciadas (DTNs), características de regiões menos desenvolvidas do planeta com baixos níveis de escolaridade, habitação e saneamento básico estão sujeitas às opções terapêuticas limitadas e ineficientes. A cada ano, cerca de 250 milhões de casos de malária são diagnosticados e aproximadamente um milhão de pessoas morre desta doença. A baixa eficácia, elevada toxicidade e a emergência de cepas de parasitas resistentes à fármacos, são fatores que determinam a necessidade da síntese de novos fármacos e programas de investimentos e inovação em pesquisa e desenvolvimento (P&D). A proposta de compostos híbridos ou funcionalização de moléculas, como também pode ser chamada, é uma abordagem bem estabelecida para síntese de fármacos. Moléculas híbridas ganham destaque com o uso em várias áreas terapêuticas, tais como inflamação, alergia, depressão, propostas quimioterápicas contra o câncer e parasitemia. Recentemente as atividades biológicas de compostos de Selênio têm recebido crescente atenção, em especial os derivados hipervalentes de Selênio (IV) que têm sido estudados por nosso grupo de pesquisas como inibidores de cisteína peptidases. O merecido destaque dos compostos de Selênio hipervalentes, avaliados como inibidores enzimáticos aumentam as chances de encontrar inibidores mais eficientes e seletivos para enzimas envolvidas em infecções parasitárias. Neste sentido, esse trabalho propôs a junção de duas propriedades químicas que atuam contra o desenvolvimento do Plasmodium falciparum (protozoário responsável pela Malária): a inibição da heme-polimerase através da ação de sistemas hetrocíclicos nitrogenados (como bases fracas), e a inibição de cisteína peptidases com a atuação das selenuranas, as quais reduzem o efluxo da droga em cepas resistentes a outros fármacos. Os compostos sintetizados foram submetidos a testes biológicos para a avaliação de seu potencial como quimioterápicos para a malária. Os compostos foram eficientes na inibição do desenvolvimento dos parasitas in vitro e mostraram interferir na homeostase celular. Além disso, não causaram hemólise e nem diminuição significativa da viabilidade de células endoteliais. Juntos, os resultados obtidos mostram que esses compostos são potenciais candidatos para desenvolvimento de novos fármacos, uma vez que é letal ao parasita e contém os benefícios de composto híbrido. / Neglected tropical diseases (NTDs), typical of less developed regions of the world with low levels of education, habitation and sanitation are subject to limited and ineffective treatment options. Each year, about 250 million cases of Malaria are diagnosed and about 1 million people die of this disease. The low efficacy, high toxicity and the emergence of chloroquine resistant in Plasmodium falciparum strains are factors that determine the necessity for synthesis of new drugs and investments and innovations programs in research and development (R&D). The proposed of hybrid compounds, or they are also called functionalization of molecules, is a well-established approach to synthesis of drugs. Hybrid molecules are highlighted on use in various therapeutic areas such as inflammation, allergy, depression, proposals for cancer and parasitosis chemotherapy. Recently the biological activities of selenium compounds has received great attention, particularly hypervalent derivatives of selenium (IV) that it has been studied by our research group as inhibitors of cysteine peptidases. The worth prominence of hypervalent selenium compounds evaluated as enzyme inhibitors, which increase the chances of finding more efficient and selective for enzymes involved in parasitic infections inhibitors . In this way, this work proposed the addition of two chemical properties that act against the development of Plasmodium falciparum (protozoan responsible for Malaria). Inhibition of heme polymerase by way of the action of amino groups (such as weak bases), and inhibition of cysteine peptidases with the performance of selenuranes reduces the efflux of drug in resistant strains to other drugs. The synthesized compounds were subjected to biological evaluation of their potential as chemotherapeutic agents for Malaria tests. The compounds were effective in inhibiting the development of parasites in vitro and interference on cellular homeostasis. In addition, didn¿t cause hemolysis or a significant decrease in viability of endothelial cells. Together, the results show that these compounds are good candidates for development of new drugs since it is lethal to the parasite, does not harm the host and has the benefits of a hybrid compound.

The work centersaround perfluoroaryl azides (PFAAs), and theirability to undergo certain fast and robusttransformations. The chemistry was furtherappliedfor biomedical applications. The first section focuses on the azide-aldehyde-amine cycloaddition using PFAAs. Experimental and computational investigations uncovered a fast azide-enamine cycloaddition to form triazolines, which spontaneously rearrange into stable amidine products. In addition, this transformation was explored in the formulation of pure nanodrugs. Because this reaction can introduce a phenyl and a perfluoroaryl moiety enabling supramolecular interactions near the antibiotic drug, the resulting ciprofloxacin derivatives formed nano-sized aggregates by precipitation, which displayed aggregation-induced emission for bacterial imaging as well as enhanced size-dependent antibacterial efficacy. In the second section, the high electrophilicity of PFAAs was explored to transform azides to aryl amides. The reactivity of PFAAs in the thioacid/azide reaction was studied. In addition, PFAAs were discovered to react with phenylacetaldehyde to form aryl amidesviaan azide-enol cycloaddition, similar tothe perfluoroaryl azide-aldehyde-amine reaction.This strategyof amide synthesiswas furthermoregeneralized through a combination of base-catalyzed azide-enolate cycloaddition reaction and acid-or heat-promoted rearrangement of triazolines. The last section describes a type of azide fluorogens whose fluorescence can be switched on by alight-initiated intramolecular nitrene insertion intoa C-H bond in the neighboring aromaticring. These fluorogenic structures were efficiently accessed via the direct nucleophilic aromatic substitution of PFAAs. / <p>QC 20150903</p>

Les produits appartenant à la famille des pyridopyrimidines sont caractérisés par leur intense utilisation dans le domaine pharmacologique, ce qui a poussé différentes équipes de recherche, de par le monde, à les étudier chimiquement et biologiquement. Dans ce travail, nous nous sommes intéressés au groupe des pyridopyrimidines et, plus particulièrement, à l’isomère le moins décrit dans la littérature, à savoir les pyrido[3,2-d]pyrimidines. Les composés ciblés sont synthétisés à partir de la 2,7-dichloropyrido[3,2-d]pyrimidine, via des substitutions nucléophiles aromatiques et des couplages pallado-catalysés et ce, dans le but d’obtenir de puissants inhibiteurs de kinases. Ce but a été atteint puisqu’en effet plusieurs des molécules élaborées inhibent les kinases testées avec des concentrations de l’ordre du nanomolaire. Des résultats pharmacologiques aussi concluants nous ont amenés à étendre nos études à d’autres pyridopyrimidines, à savoir les pyrido[2,3-d]pyrimidines ainsi qu’à d’autres types de bicycles polyazotés, en l’occurrence les imidazo[1,2-a]pyridines et les imidazo[1,2-b]pyridazines. / Products belonging to the pyridopyrimidine family are characterized by their intense use in pharmacology. The increase of interest for this heterocyclic scaffold prompted different research teams around the world to study their chemically and biologically properties. In this work, we are interested in the functionalization of pyridopyrimidines and, more specifically, of the less described regioisomer, namely pyrido[3,2-d]pyrimidines. The target compounds were synthesized from 2,7-dichloropyrido[3,2-d]pyrimidine via nucleophilic aromatic substitution and palladium-catalyzed couplings and, in order to obtain potent kinases inhibitors. Our goal has been achieved with several elaborate molecules. These bioactive compounds inhibit kinases such as Cyclin Dependant Kinases (CDK), Glycogen Synthase 3 (GSK3) or Dual specificity tYRosine-phosphorylation-regulated Kinase 1A (DYRK1A) in the nanomolar range. These biological targets are mainly involved in degenerative process or down syndrome. These pharmacological results led us to extend our studies to other pyridopyrimidines, namely pyrido[2,3-d]pyrimidines as well as other types of polynitrogenated bicycles, namely imidazo[1,2- a]pyridine and imidazo[1,2-b]pyridazine.

Cette thèse comporte deux parties indépendantes. La première étude présente les premiers exemples de métallation de la structure azobenzène par les réactifs organométalliques polaires. Largement utilisés en tant que colorants, les azobenzènes trouvent actuellement de nombreuses applications dans le domaine des matériaux en raison de leur facile photoisomerisation E/Z. Il est montré que les bases organométalliques polaires classiques (n-BuLi, n-BuLi/TMEDA, n-BuLi/t-BuOK, TMPMgCl.LiCl, LDA) ne métallent pas l’azobenzène parent mais réduisent plutôt la liaison N=N. Cependant la métallation est possible avec le tétraméthylpipéridure de lithium si un groupement directeur de métallation tel que le méthoxy (OMe), diéthylamide (CONEt2) ou fluoro (F) est présent sur l’azobenzène. La réaction permet un accès original et direct à de nouveaux azobenzènes substitués. L’objectif de la deuxième partie est la synthèse de dérivés biaryliques chiraux en l’absence de métaux de transition (Pd, Ni…). Les biaryles chiraux sont présents dans de nombreuses molécules biologiquement actives et peuvent être utilisés comme ligands pour la catalyse asymétrique. La substitution nucléophile aromatique des acides naphtoïques en présence de ligands chiraux a été étudiée. Une optimisation fine des conditions réactionnelles (choix du solvant, température, structure du ligand…) a permis de préparer des 1,1’-binaphtalènes, 1,2’-binaphtalènes et phénylnaphtalènes avec de bons rendements et excès énantiomériques (jusqu’à 89% ee). La substitution nucléophile aromatique atroposélective de dérivés d’acides naphtoïques de type naphtyloxazolines et naphtoates est également décrite. / This thesis is divided into two independant parts. The first part describes for the first time the chemoselective lithiation of azobenzenes. Azobenzenes derivatives are widely used as dyes and more recently have been applied to the preparation of photoresponsive molecular switches and materials by taking advantage of the N=N bond E/Z photoisomerization. Whereas standard polar organometallics (n-BuLi, n-BuLi/TMEDA, n-BuLi/t-BuOK, TMPMgCl.LiCl, LDA) reduce the N=N bond of the parent compound, aromatic HLi permutation occurs with LTMP when a suitable director of lithiation (OMe, CONEt2, F) is present in the benzene residue of the azo compound. The method allows a direct access to new substituted azobenzenes.Axially chiral biaryls, which are found in many biologically active natural products, are conventionally used as ligands for asymmetric catalysis. The purpose of the second part is to develop a new method for the preparation of axially chiral biaryls in the absence of transition metals (Pd, Ni…). To tackle that goal, nucleophilic aromatic substitution reactions on unprotected naphthoic acids were performed in the presence of chiral ligands. A careful optimization of the reaction parameters (choice of the solvent, temperature, structure of the ligand…) allowed to prepare chiral 1,1’- binaphthalenes 1,2’- binaphthalenes and phenylnaphthalenes in good yields and enantiomeric excesses (up to 89% ee). The atroposelective SNAr reaction of naphthyloxazoline and naphthoate derivatives was also reported.